IBDEI106 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17967,1,2,0)
 ;;=2^295.40
 ;;^UTILITY(U,$J,358.3,17967,1,5,0)
 ;;=5^Schizophreniform Disorder NOS
 ;;^UTILITY(U,$J,358.3,17967,2)
 ;;=^331845
 ;;^UTILITY(U,$J,358.3,17968,0)
 ;;=295.50^^116^1115^4
 ;;^UTILITY(U,$J,358.3,17968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17968,1,2,0)
 ;;=2^295.50
 ;;^UTILITY(U,$J,358.3,17968,1,5,0)
 ;;=5^Latent Schizophrenia NOS
 ;;^UTILITY(U,$J,358.3,17968,2)
 ;;=^68517
 ;;^UTILITY(U,$J,358.3,17969,0)
 ;;=295.60^^116^1115^22
 ;;^UTILITY(U,$J,358.3,17969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17969,1,2,0)
 ;;=2^295.60
 ;;^UTILITY(U,$J,358.3,17969,1,5,0)
 ;;=5^Undifferentiated Schizophrenia NOS
 ;;^UTILITY(U,$J,358.3,17969,2)
 ;;=^331851
 ;;^UTILITY(U,$J,358.3,17970,0)
 ;;=295.70^^116^1115^10
 ;;^UTILITY(U,$J,358.3,17970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17970,1,2,0)
 ;;=2^295.70
 ;;^UTILITY(U,$J,358.3,17970,1,5,0)
 ;;=5^Schizoaffective Disorder NOS
 ;;^UTILITY(U,$J,358.3,17970,2)
 ;;=^331857
 ;;^UTILITY(U,$J,358.3,17971,0)
 ;;=295.90^^116^1115^13
 ;;^UTILITY(U,$J,358.3,17971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17971,1,2,0)
 ;;=2^295.90
 ;;^UTILITY(U,$J,358.3,17971,1,5,0)
 ;;=5^Schizophrenia NOS,Unspec
 ;;^UTILITY(U,$J,358.3,17971,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,17972,0)
 ;;=307.1^^116^1116^1
 ;;^UTILITY(U,$J,358.3,17972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17972,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,17972,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,17972,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,17973,0)
 ;;=307.51^^116^1116^2
 ;;^UTILITY(U,$J,358.3,17973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17973,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,17973,1,5,0)
 ;;=5^Bulemia
 ;;^UTILITY(U,$J,358.3,17973,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,17974,0)
 ;;=307.50^^116^1116^3
 ;;^UTILITY(U,$J,358.3,17974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17974,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,17974,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,17974,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,17975,0)
 ;;=V87.39^^116^1117^1
 ;;^UTILITY(U,$J,358.3,17975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17975,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,17975,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,17975,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,17976,0)
 ;;=310.0^^116^1118^1
 ;;^UTILITY(U,$J,358.3,17976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17976,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,17976,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,17976,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,17977,0)
 ;;=310.1^^116^1118^4
 ;;^UTILITY(U,$J,358.3,17977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17977,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,17977,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,17977,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,17978,0)
 ;;=310.2^^116^1118^5
 ;;^UTILITY(U,$J,358.3,17978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17978,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,17978,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,17978,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,17979,0)
 ;;=310.81^^116^1118^6
 ;;^UTILITY(U,$J,358.3,17979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17979,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,17979,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,17979,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,17980,0)
 ;;=907.0^^116^1118^2
 ;;^UTILITY(U,$J,358.3,17980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17980,1,2,0)
 ;;=2^907.0
 ;;^UTILITY(U,$J,358.3,17980,1,5,0)
 ;;=5^Late Effect Intracranial Inj
